Establishment Labs Holdings Inc
NASDAQ:ESTA
Intrinsic Value
Establishment Labs Holdings, Inc. is a technology company, which engages in the design, development, manufacture, and marketing of silicone breast implants. [ Read More ]
The intrinsic value of one
ESTA
stock under the Base Case scenario is
28
USD.
Compared to the current market price of 53.35 USD,
Establishment Labs Holdings Inc
is
Overvalued by 48%.
Establishment Labs Holdings Inc's market capitalization is 1.4B USD.
ESTA stock price is 53.35 USD.
ESTA stock (28 USD) is 48% less than its price (53.35 USD).
ESTA stock (46.14 USD) is 14% less than its price (53.35 USD). Open Relative Valuation
ESTA has upside potential of 15% compared to the average analyst price target.
Open Wall St Estimates
ESTA's Revenue has grown by 2% over the past 12 months.
ESTA's long-term assets (269m USD) exceed its long-term liabilties (250m USD).
ESTA's ROIC (Return on Invested Capital) has decreased in the last 3 years from -34% to -42%, and is approaching profitability.
ESTA's Revenue is forecast to grow at a rate of 26% per year over the next 3 years.
ESTA's ROE (Return on Equity) has significantly decreased in the last 3 years from -34% to -1 540%, and is approaching profitability.
ESTA's Revenue has been growing by an exceptional 25% per year for the last 3 years.
ESTA has negative Operating Income for the last twelve months.
ESTA has negative Net Income for the last twelve months.
ESTA's ROE (Return on Equity) for the past 12 months is negative and is equal to -1 540%.
ESTA's ROIC (Return on Invested Capital) for the past 12 months is negative and is equal to -42%.
ESTA has positive Gross Profit for the last twelve months.
ESTA has positive Net Debt. This means that the company has more debt (189m USD) than cash and short-term investments (40m USD).
ESTA's short-term assets (175m USD) exceed its short-term liabilties (57m USD).
ESTA has negative Free Cash Flow for the last twelve months.
ESTA has negative three-year average ROE (Return on Equity): -288%. The company is not efficient at transforming stockholders' equity into net income.
ESTA has negative three-year average ROIC (Return on Invested Capital): -40%. The company is not efficient at using invested capital to generate operating income.
ESTA's D/E (Debt to Equity) is very high and is equal to 10.26.
ESTA's Altman Z-Score is very low and is equal to -0.09.
ESTA doesn't generate enough operating income (-65m USD) to safely cover interest payments on its debt (6m USD).
Valuation Backtest
Establishment Labs Holdings Inc
Run backtest to discover the historical profit from buying and selling
ESTA
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Establishment Labs Holdings Inc
Balance Sheet Decomposition
Establishment Labs Holdings Inc
| Current Assets | 174.9m |
| Cash & Short-Term Investments | 40m |
| Receivables | 48m |
| Other Current Assets | 86.9m |
| Non-Current Assets | 93.7m |
| PP&E | 80.6m |
| Intangibles | 8.5m |
| Other Non-Current Assets | 4.7m |
| Current Liabilities | 57.2m |
| Accounts Payable | 41.6m |
| Accrued Liabilities | 13.6m |
| Other Current Liabilities | 1.9m |
| Non-Current Liabilities | 193.1m |
| Long-Term Debt | 188.7m |
| Other Non-Current Liabilities | 4.4m |
Earnings Waterfall
Establishment Labs Holdings Inc
|
Revenue
|
165.2m
USD
|
|
Cost of Revenue
|
-58.2m
USD
|
|
Gross Profit
|
107m
USD
|
|
Operating Expenses
|
-172m
USD
|
|
Operating Income
|
-65m
USD
|
|
Other Expenses
|
-13.5m
USD
|
|
Net Income
|
-78.5m
USD
|
Free Cash Flow Analysis
Establishment Labs Holdings Inc
What is Free Cash Flow?
ESTA Profitability Score
Profitability Due Diligence
Establishment Labs Holdings Inc's profitability score is 25/100. The higher the profitability score, the more profitable the company is.
Score
Establishment Labs Holdings Inc's profitability score is 25/100. The higher the profitability score, the more profitable the company is.
ESTA Solvency Score
Solvency Due Diligence
Establishment Labs Holdings Inc's solvency score is 22/100. The higher the solvency score, the more solvent the company is.
Score
Establishment Labs Holdings Inc's solvency score is 22/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ESTA Price Targets Summary
Establishment Labs Holdings Inc
According to Wall Street analysts, the average 1-year price target for
ESTA
is 61.54 USD
with a low forecast of 50.5 USD and a high forecast of 68.25 USD.
Ownership
ESTA Insider Trading
Buy and sell transactions by insiders
| Period | Sold | Bought | Net |
|---|---|---|---|
| 3 Months |
|
|
|
| 6 Months |
|
|
|
| 9 Months |
|
|
|
| 12 Months |
|
|
|
Shareholder Return
ESTA Price
Establishment Labs Holdings Inc
| Average Annual Return | 32.56% |
| Standard Deviation of Annual Returns | 41.31% |
| Max Drawdown | -75% |
| Market Capitalization | 1.4B USD |
| Shares Outstanding | 27 210 000 |
| Percentage of Shares Shorted | 23.53% |
Company Profile
Establishment Labs Holdings Inc
Country
Industry
Market Cap
Dividend Yield
Description
Establishment Labs Holdings, Inc. is a technology company, which engages in the design, development, manufacture, and marketing of silicone breast implants. The company is headquartered in Alajuela, Alajuela and currently employs 746 full-time employees. The company went IPO on 2018-07-19. The firm is engaged in the designing, developing, manufacturing and marketing of product portfolio consisting of silicone-filled breast and body shaping implants. Its line of silicone gel-filled breast implants, branded as MotivaImplants, is the centerpiece of its MotivaImagine medical technology platform. The Company’s MotivaImplants are sold in over 60 countries.
Contact
IPO
Employees
Officers
The intrinsic value of one
ESTA
stock under the Base Case scenario is
28
USD.
Compared to the current market price of 53.35 USD,
Establishment Labs Holdings Inc
is
Overvalued by 48%.
You don't have any saved screeners yet
